Jul 04, 2015 – WHO-GMP

As a reaffirmation of our commitment to quality assurance and quality risk management, the Roorkee manufacturing facility received WHO-GMP accreditation today. It is a significant milestone for this facility with the installed capacity to manufacture, per day , 60 Lac tablets, 5 Lac capsules, 1,50,000 units of topical formulations,40,000 units of liquid orals, 20,000 units of dry syrup and 10,000 units of sterile injectables